Moore M, Gill S, Asmis T, Berry S, Burkes R, Zbuk K, et al
This is also consistent with our recent work showing that different ITCs lead to various degree of growth inhibition depending on their side chain structure 74
Tools within the WeightWatchers GLP-1 Success program, such as meal planning and habit tracking, help connect your medication use with everyday routines
Conditions to consider include androgenetic alopecia, autoimmune alopecia, thyroid disorders, tinea capitis (fungal infection), lichen planopilaris or other scarring alopecias, systemic illness, or other dermatologic conditions unrelated to GLP-1 therapy or weight loss
Tirzepatide is a once-weekly injectable medication approved by the FDA for the treatment of type 2 diabetes (marketed as Mounjaro) and chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity (marketed as Zepbound)
